Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - CYTOKINETICS INC | f59630e10vq.htm |
| EX-31.1 - EX-31.1 - CYTOKINETICS INC | f59630exv31w1.htm |
| EX-10.2 - EX-10.2 - CYTOKINETICS INC | f59630exv10w2.htm |
| EX-32.1 - EX-32.1 - CYTOKINETICS INC | f59630exv32w1.htm |
| EX-31.2 - EX-31.2 - CYTOKINETICS INC | f59630exv31w2.htm |
| EXCEL - IDEA: XBRL DOCUMENT - CYTOKINETICS INC | Financial_Report.xls |
Exhibit 3.2
CERTIFICATE OF AMENDMENT OF
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF
CYTOKINETICS, INCORPORATED
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF
CYTOKINETICS, INCORPORATED
Cytokinetics, Incorporated, a corporation organized and existing under and by virtue
of the General Corporation Law of the State of Delaware (the “Corporation”), hereby certifies
that:
1. The original name of the Corporation is Cytokinetics,
Incorporated.
2. The date on which the Certificate of Incorporation of the Corporation was
originally filed with the Secretary of State of the State of Delaware was August 5, 1997.
3. The Board of Directors of the Corporation, acting in accordance with the
provisions of Sections 141 and 242 of the General Corporation Law of the State of Delaware, adopted
resolutions amending the Amended and Restated Certificate of Incorporation of the Corporation to
increase the number of authorized shares of Common Stock to 245,000,000. Specifically, the first
sentence of Article IV is hereby amended by deleting “170,000,000 shares of Common Stock” and
replacing the same with “245,000,000 shares of Common Stock”.
4. This Certificate of Amendment was duly adopted by the stockholders of the
Corporation in accordance with the provisions of Sections 228 and 242 of the General Corporation
Law of the State of Delaware.
[Signature Page Follows]
In Witness Whereof, the Corporation has caused this Certificate of Amendment to be
signed by its President and Chief Executive Officer this 28 day of July, 2011.
| CYTOKINETICS, INCORPORATED |
||||
| By: | /s/ Robert I. Blum | |||
| Robert I. Blum | ||||
| President and Chief Executive Officer | ||||